Extracellular Volume Fraction Combined With Pathological Features of α‐SMA and FAP for Predicting the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma After Surgery and Evaluating the Efficacy of Chemotherapy

Documenti analoghi

• Ubiquitination‐Associated Ductal–Fibroblast Crosstalk Shapes Tumor Progression and Prognosis in Pancreatic Ductal Adenocarcinoma
  di: Yiping Fu, et al.
  Pubblicazione: (2026)
• Neoadjuvant Therapy‐Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis
  di: Xiaofei Zhang, et al.
  Pubblicazione: (2026)
• Improved Predictability of Diagnosis and Prognosis Using Serum‐ and Tissue‐Derived Extracellular Vesicles From Bulk mRNA Sequencing in Pancreatic Ductal Adenocarcinoma
  di: Qian Zhu, et al.
  Pubblicazione: (2025)
• Aspartame Increases the Risk of Pancreatic Ductal Adenocarcinoma
  di: Jumin Xie, et al.
  Pubblicazione: (2026)
• Mouth to Bile: Microbiome Shifts in Pancreatic Ductal Adenocarcinoma
  di: Joha De Maayer, et al.
  Pubblicazione: (2026)